No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
NVAX250117P11500
- 3.06
- 0.000.00%
15min DelayTrading Jan 13 10:45 ET
0.00High0.00Low
0.00Open3.06Pre Close0 Volume4 Open Interest11.50Strike Price0.00Turnover211.89%IV3.54%PremiumJan 17, 2025Expiry Date2.75Intrinsic Value100Multiplier2DDays to Expiry0.31Extrinsic Value100Contract SizeAmericanOptions Type-0.9307Delta0.0908Gamma2.86Leverage Ratio-0.0330Theta-0.0006Rho-2.66Eff Leverage0.0009Vega
Intraday
- 5D
- Daily
No Data
News
Looking Into Novavax's Recent Short Interest
Why Novavax (NVAX) Stock Is Falling
Novavax Shares Strategic Updates at Healthcare Conference
Express News | Novavax reaffirms its annual revenue expectations.
Express News | Novavax Inc - Reaffirms Full Year 2024 Guidance
Shares of Vaccine Stocks Are Trading Lower After Moderna Issued 2025 Revenue Guidance Below Analyst Estimates.